About King Laboratories
King Laboratories is a company. King Laboratories offers products and services including Generic Drugs and Oncology Therapies.
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Social
Locked
- Legal Name King Laboratories Private Limited
- Jurisdiction Srinagar, Jammu & Kashmir, India
-
Annual Revenue
$79.42 K (USD)-24.17as on Mar 31, 2017
-
Net Profit
$624.26 (USD)-23.82as on Mar 31, 2017
-
EBITDA
-$7.07 K (USD)-182.18as on Mar 31, 2017
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of King Laboratories
King Laboratories offers a comprehensive portfolio of products and services, including Generic Drugs and Oncology Therapies.
Generic drugs are manufactured by King Laboratories for major therapeutic segments, covering dosage forms like oral solids and powders, with a focus on vertical integration and global distribution.
Oncology therapies are developed by King Laboratories as advanced treatments for enriching patient lives, including biosimilars and formulations that are supported by research centers worldwide.
Funding Insights of King Laboratories
Detailed funding history for King Laboratories
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by King Laboratories
Investment portfolio details for King Laboratories
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - King Laboratories
Detailed financials for King Laboratories
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
King Laboratories Comparisons
Peer comparison for King Laboratories
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of King Laboratories
Detailed competitors of King Laboratories
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on King Laboratories
Complete news archive for King Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about King Laboratories
Annual revenue of King Laboratories is $79.42K as on Mar 31, 2017.
King Laboratories is recognized as a research-based pharmaceutical entity that operates with offices in over 50 countries and manufacturing facilities in four nations, where advanced therapies for dermatology, oncology, and respiratory conditions are developed to improve patient quality of life globally. Investments in research and development, including 6-7 of turnover and over 1,00,000 sq ft of dedicated space, are utilized by a team of 550 scientists to create generics, biosimilars, and parenteral products. Accreditations from international regulatory bodies are held by the company, ensuring compliance and a competitive edge in the generic market, while environmental health and safety standards are maintained through ongoing resource allocation. This structure supports a vertically-integrated approach across the pharmaceutical value chain, fostering innovation in differentiated medicines.
King Laboratories offers Generic Drugs and Oncology Therapies.